ArticleEuropean heart journal. Case reports2026
From angiography-derived physiology guided PCI to INOCA treatment and to coronary sinus reducer: navigating multiple pathophysiological targets in a single patient: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intermediate coronary lesions without clear ischaemia should prompt physiological assessment during angiography. Angiography-derived fractional flow reserve enables rapid, wire-free evaluation of lesion significance and can guide revascularization decisions. Persistent angina despite successful percutaneous coronary intervention (PCI) should raise suspicion for concomitant microvascular dysfunction, warranting microcirculation assessment to identify the mechanism and tailor therapy. When no further epicardial target exists and symptoms remain refractory despite comprehensive medical management, coronary sinus reducer (CSR) implantation can be considered. Although these three domains have rapidly evolved over the past few years, they are rarely combined sequentially. This case report illustrates how the stepwise use of these contemporary tools, each addressing a distinct pathophysiological mechanism, led to a marked improvement in the patient's symptoms and overall clinical course. Case summary: A 45-year-old man presented with acute coronary syndrome and underwent multivessel PCI in 2023. One year later, he re-presented with unstable angina and received optical coherence tomography-guided left main to left anterior descending artery stenting. However, symptoms persisted (Canadian Cardiovascular Society class II). Invasive coronary function testing revealed impaired vasodilatory reserve with preserved microvascular resistance and no inducible spasm, suggesting functional impairment of vasodilatory capacity. Mechanism-matched therapy with calcium-channel blockade and angiotensin-converting enzyme inhibition provided partial relief. Refractory angina ultimately led to CSR implantation with complete resolution of symptoms. Discussion: This case highlights a stepwise physiology-first approach, progressing from epicardial revascularization to ischaemia with no obstructive coronary arteries phenotyping and ultimately venous outflow modulation for refractory angina.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.